Clinically, Kras-mutant LUAD is dominated in three robust subsets of molecular lung cancer classifications, among which inactivation of the liver kinase B1 [Lkb1; or named as Serine/threonine kinase 11 (Stk11)] is the most frequently co-occurring events [2,3,4]. The gene discussed is STK11; the disease is lung cancer.